Company Analysis

Bone Biologics Corp (BBLG)

Nasdaq: BBLG · Orthopedic, Prosthetic & Surgical Appliances & Supplies · Burlington, MA · filing with the SEC since 2008
Grade4.4
◀ Past 2.8● Present 5.2▶ Future 4.9
5 est.

Who runs Bone Biologics Corp

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Frelick Jeff
Chief Executive Officer. First filing Aug 2015, latest Jan 21, 2026, 2 filings in all.
Officers reporting now
2
of 6 people with a filing in the last fifteen months
Directors reporting now
4
18 people on the record since 2008
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Frelick JeffChief Executive OfficerAug 2015Jan 21, 2026none
Walsh Deina HChief Financial OfficerOct 2015Jan 21, 2026none
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Angle Siddhesh RajendradirectorOct 2021Sep 30, 2026none
Gagnon Robert E.directorJan 2024Sep 30, 2026none
Meikle Phillip Terry IIdirectorOct 2024Sep 30, 2026none
Stroever BrucedirectorNov 2015Sep 30, 2026none
Earlier names on the record16, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton BBLG · research, not advice